HomeADVM • NASDAQ
add
Adverum Biotechnologies Inc
Nakaraang pagsara
$4.36
Sakop ng taon
$1.78 - $6.07
Market cap
96.26M USD
Average na Volume
498.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 46.94M | 36.66% |
Net na kita | -47.65M | -47.30% |
Net profit margin | — | — |
Kita sa bawat share | -2.03 | -56.15% |
EBITDA | -47.56M | -41.76% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 26.06M | -82.99% |
Kabuuang asset | 72.40M | -69.11% |
Kabuuang sagutin | 128.05M | 41.87% |
Kabuuang equity | -55.65M | — |
Natitirang share | 22.08M | — |
Presyo para makapag-book | -1.72 | — |
Return on assets | -142.43% | — |
Return on capital | -228.05% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -47.65M | -47.30% |
Cash mula sa mga operasyon | -28.12M | -33.10% |
Cash mula sa pag-invest | 1.86M | 113.92% |
Cash mula sa financing | 9.90M | — |
Net change in cash | -16.36M | 52.54% |
Malayang cash flow | -11.26M | 25.10% |
Tungkol
Adverum Biotechnologies, Inc. is a publicly traded clinical stage gene therapy company located in Redwood City, California. It is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Itinatag
Ene 1, 2006
Headquarters
Website
Mga Empleyado
155
